National and Kapodistrian University of Athens
Επίδραση της αγωγής με πεγκυλιωμένη ιντερφερόνη και ριμπαβιρίνη στο παχύ έντερο ασθενών με χρόνια HCV λοίμωξη
Abstract
dc:descriptionThe aim of the present study was to evaluate the possible effect of interferon plus ribavirin treatment on the large intestine histology of chronic HCV infected patients as well as its possible relationship with diarrhea, a recognized complication of this treatment regimen. Twenty-four treatment-naive chronic HCV infected patients with no contraindication of receiving combination treatment with pegylated-interferon alpha-2b (PEG-IFNα2b) and ribavirin (RIB) were enrolled in the study. All patients underwent recto-sigmoidoscopic examination prior to the beginning of the treatment schedule. Three to five biopsy specimens were taken from the recto-sigmoid area. Fifteen patients underwent the same procedure after the completion of a 6-month treatment course. Nine patients refused to proceed with the study (6) or stopped the treatment due to personal reasons (3). Ten age-matched healthy subjects (control group) underwent recto-sigmoidoscopic examination and biopsy. All controls had no history of inflammatory bowel disease or other diseases, did not receive non-steroid anti-inflammatory medications, did not report diarrhea and were used to identify possible large intestine’s histology lesions in chronic HCV infected patients. Twenty percent (20%) of patients reported diarrhea during or after 6 months of treatment, unrelated to the histology of the large intestine. No pathological macroscopic (endoscopic) findings were identified in either patients or controls. The group of patients had no statistically significant difference in the presence of inflammation compared to controls. In particular, no statistically significant differences were observed regarding architectural disorder and mucus production, the presence of Paneth cells and the number of lymphoid follicles in every biopsy specimen among patients and controls. Therefore, it seems that chronic HCV infection is not responsible for histological alterations of the intestinal mucosa. Additionally, there was no statistically significant difference to the percentage of patients with large intestine inflammation before and 6 months after treatment. No statistically significant differences were observed regarding architectural disorder, decrease of mucus production, presence of Paneth cells and the number of lymphoid follicles in every biopsy specimen, before and 6 months after combination treatment. So, it seems that combination treatment with PEG-IFNα2b and ribavirin has no effect on the large intestine histology of chronic HCV infected patients. Conclusively, according to the results of our study, chronic HCV infection doesn’t seem to affect the histology of the large intestine, despite the documental lymphotropism of hepatitis C virus. Moreover, it seems that the immunomodulatory-antiviral treatment of chronic hepatitis C doesn’t affect the large intestine histology of treated patients, despite the appearance of symptoms from the gastro-intestinal tract in a subgroup of them.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2006
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Pantazis, Konstantinos
- Πανταζής, Κωνσταντίνος
Subjects
dc:subject × 12Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/14137